LU91235I2 - Palifermin et ses dérivés pharmaceutiquement acceptables (KEPIVANCE) - Google Patents

Palifermin et ses dérivés pharmaceutiquement acceptables (KEPIVANCE)

Info

Publication number: LU91235I2
Authority: LU; Luxembourg
Prior art keywords: kepivance; palifermin; pharmaceutically acceptable; acceptable derivatives; derivatives
Prior art date: 1994-10-13

Application number

LU91235C

Other languages

English (en)

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-13

Filing date

2006-04-12

Publication date

2006-11-22

1995-06-07 Priority claimed from US08/487,830 external-priority patent/US6008328A/en

2006-04-12 Application filed by Amgen Inc filed Critical Amgen Inc

2006-11-22 Publication of LU91235I2 publication Critical patent/LU91235I2/fr

Links

102000003972 Fibroblast growth factor 7 Human genes 0.000 title 1
108090000385 Fibroblast growth factor 7 Proteins 0.000 title 1
229940065223 kepivance Drugs 0.000 title 1
229960002404 palifermin Drugs 0.000 title 1
239000003102 growth factor Substances 0.000 abstract 1
210000002510 keratinocyte Anatomy 0.000 abstract 1
238000000746 purification Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Steroid Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

LU91235C 1994-10-13 2006-04-12 Palifermin et ses dérivés pharmaceutiquement acceptables (KEPIVANCE) LU91235I2 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US32333994A	1994-10-13	1994-10-13
US08/487,830 US6008328A (en)	1994-10-13	1995-06-07	Method for purifying keratinocyte growth factors
PCT/US1995/013099 WO1996011952A1 (fr)	1994-10-13	1995-10-12	Procede pour purifier des facteurs de croissance des keratinocytes

Publications (1)

Publication Number	Publication Date
LU91235I2 true LU91235I2 (fr)	2006-11-22

Family

ID=26983902

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU91235C LU91235I2 (fr)	1994-10-13	2006-04-12	Palifermin et ses dérivés pharmaceutiquement acceptables (KEPIVANCE)

Country Status (18)

Country	Link
EP (2)	EP0785949B1 (fr)
JP (1)	JP3877226B2 (fr)
CN (1)	CN1161380C (fr)
AT (1)	ATE239038T1 (fr)
CA (1)	CA2201762C (fr)
CZ (1)	CZ98297A3 (fr)
DE (2)	DE122006000019I1 (fr)
DK (1)	DK0785949T3 (fr)
ES (1)	ES2197926T3 (fr)
HU (1)	HU220584B1 (fr)
IL (3)	IL147575A (fr)
LU (1)	LU91235I2 (fr)
NL (1)	NL300229I2 (fr)
NO (1)	NO971567L (fr)
PT (1)	PT785949E (fr)
SI (1)	SI0785949T1 (fr)
SK (1)	SK43097A3 (fr)
WO (1)	WO1996011952A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7232667B2 (en)	1995-02-14	2007-06-19	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 polynucleotides
US6077692A (en) *	1995-02-14	2000-06-20	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US6693077B1 (en)	1995-02-14	2004-02-17	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US6743422B1 (en)	1996-10-15	2004-06-01	Amgen, Inc.	Keratinocyte growth factor-2 products
AU1905799A (en)	1997-12-22	1999-07-12	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
US6869927B1 (en)	1997-12-22	2005-03-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
JP2004526437A (ja) *	2001-02-06	2004-09-02	メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング	低減された免疫原性を有する修飾されたケラチノサイト成長因子（ｋｇｆ）
AU2002326742B2 (en) *	2001-08-21	2007-05-31	Novartis Vaccines And Diagnostics, Inc.	KGF polypeptide compositions
CN102242124B (zh) *	2010-05-10	2013-05-22	齐鲁制药有限公司	改造的角化细胞生长因子基因及其在酵母中的表达
CN102675449B (zh) *	2011-03-17	2016-06-08	重庆富进生物医药有限公司	缺失型人角质细胞生长因子-ⅰ二硫键变构体及其用途
CN109402130A (zh) *	2018-11-23	2019-03-01	成都中医药大学附属医院	一种重组人角质细胞生长因子-1及其制备方法和用途
CN110183529B (zh) *	2019-05-23	2023-06-02	重庆派金生物科技有限公司	一种缺失型人角质细胞生长因子-1的重组制备方法
KR20230127721A (ko)	2022-02-25	2023-09-01	한국해양과학기술원	온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1990008771A1 (fr) *	1989-01-31	1990-08-09	Rubin Jeffrey S	Adn codant un facteur de croissance specifique contre des cellules epitheliales
WO1992011360A1 (fr) *	1990-12-18	1992-07-09	Amgen Inc.	Analogues du facteur de croissance acide des fibroblastes presentant une stabilite et une activite biologique ameliorees
DE69434053T2 (de) *	1993-06-29	2006-02-23	Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville	Verkürzter keratinocytenwachstumsfaktor(kgf)mit erhöhter biologischer aktivität
CA2172137C (fr) *	1993-09-24	1999-12-14	Andrew Peter Seddon	Analogues structurels de facteurs de croissance des fibroblastes, avec sequence en boucle
PT785950E (pt) *	1994-10-13	2003-09-30	Amgen Inc	Analogos do factor de crescimento de queratinocitos
EP0786000A1 (fr) *	1994-10-13	1997-07-30	Amgen Inc.	Analogues de facteur de croissance du fibroblaste acide a stabilite et activite biologique renforcees
KR100278597B1 (ko) *	1994-10-13	2001-01-15	스티븐 엠. 오드리	케라티노사이트 성장 인자의 유사체, 이 유사체를 암호하는 핵산 및 그것의 제조방법

1995
- 1995-10-12 CA CA002201762A patent/CA2201762C/fr not_active Expired - Lifetime
- 1995-10-12 DE DE1995630599 patent/DE122006000019I1/de active Pending
- 1995-10-12 CZ CZ97982A patent/CZ98297A3/cs unknown
- 1995-10-12 CN CNB951967959A patent/CN1161380C/zh not_active Expired - Lifetime
- 1995-10-12 DE DE69530599T patent/DE69530599T2/de not_active Expired - Lifetime
- 1995-10-12 AT AT95936309T patent/ATE239038T1/de active
- 1995-10-12 IL IL14757595A patent/IL147575A/en not_active IP Right Cessation
- 1995-10-12 SI SI9530657T patent/SI0785949T1/xx unknown
- 1995-10-12 DK DK95936309T patent/DK0785949T3/da active
- 1995-10-12 WO PCT/US1995/013099 patent/WO1996011952A1/fr not_active Ceased
- 1995-10-12 JP JP51337696A patent/JP3877226B2/ja not_active Expired - Lifetime
- 1995-10-12 HU HU9701514A patent/HU220584B1/hu unknown
- 1995-10-12 ES ES95936309T patent/ES2197926T3/es not_active Expired - Lifetime
- 1995-10-12 EP EP95936309A patent/EP0785949B1/fr not_active Expired - Lifetime
- 1995-10-12 IL IL11560595A patent/IL115605A/xx not_active IP Right Cessation
- 1995-10-12 PT PT95936309T patent/PT785949E/pt unknown
- 1995-10-12 EP EP02028624A patent/EP1334981B1/fr not_active Expired - Lifetime
- 1995-10-12 SK SK430-97A patent/SK43097A3/sk unknown
1997
- 1997-04-04 NO NO971567A patent/NO971567L/no unknown
2002
- 2002-01-10 IL IL14757502A patent/IL147575A0/xx active IP Right Grant
2006
- 2006-04-11 NL NL300229C patent/NL300229I2/nl unknown
- 2006-04-12 LU LU91235C patent/LU91235I2/fr unknown

Also Published As

Publication number	Publication date
NO971567L (no)	1997-06-12
DK0785949T3 (da)	2003-08-18
IL115605A (en)	2003-06-24
NO971567D0 (no)	1997-04-04
HU220584B1 (hu)	2002-03-28
IL115605A0 (en)	1996-01-19
IL147575A (en)	2004-05-12
PT785949E (pt)	2003-09-30
AU3830695A (en)	1996-05-06
DE69530599D1 (de)	2003-06-05
CN1169734A (zh)	1998-01-07
IL147575A0 (en)	2002-08-14
CZ98297A3 (cs)	1998-08-12
NL300229I2 (nl)	2006-09-01
WO1996011952A1 (fr)	1996-04-25
ATE239038T1 (de)	2003-05-15
CA2201762C (fr)	2001-12-18
EP1334981A2 (fr)	2003-08-13
NL300229I1 (nl)	2006-06-01
AU709362B2 (en)	1999-08-26
DE122006000019I1 (de)	2006-06-29
JP3877226B2 (ja)	2007-02-07
EP1334981A3 (fr)	2004-05-06
SI0785949T1 (en)	2003-08-31
EP1334981B1 (fr)	2011-01-26
JPH10507452A (ja)	1998-07-21
EP0785949B1 (fr)	2003-05-02
DE69530599T2 (de)	2003-11-13
HUT76879A (en)	1997-12-29
CN1161380C (zh)	2004-08-11
SK43097A3 (en)	1998-10-07
EP0785949A1 (fr)	1997-07-30
MX9702481A (es)	1997-07-31
ES2197926T3 (es)	2004-01-16
CA2201762A1 (fr)	1996-04-25

Similar Documents

Publication	Publication Date	Title
KR950702564A (ko)	1995-07-29	비스-스타우로스포린 및 케이-252에이(K-25a)유도체(BIS-STAUROSPORINE AND K-252a DERIVATIVES)
MX9201419A (es)	1992-10-01	Derivados de benzo isoxazol-piperidina.
AU1642795A (en)	1995-11-02	Substituted pyridylpyrazoles
ES2145915T3 (es)	2000-07-16	Derivados estereoquimicos de la wortmannina.
ES2138691T3 (es)	2000-01-16	Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
LU91673I2 (fr)	2010-06-07	"Dronédarone et ses dérivés pharmaceutiquement acceptables (MULTAQ)"
DK0695758T3 (da)	2002-08-19	Pentapeptidamider og -estere til inhibering af human cancer
DK0876392T3 (da)	2000-11-06	Lacton-derivater af 17.beta.-carboxy, carbothio og amidandrostanforbindelser
LU91235I2 (fr)	2006-11-22	Palifermin et ses dérivés pharmaceutiquement acceptables (KEPIVANCE)
DE69709938D1 (de)	2002-02-28	N-benzylpiperidin- und tetrahydropyridin-derivate
DK0451547T3 (da)	1993-12-29	1,4,8-triazacyclotridecanderivater med prolylendopeptidase inhiberende aktivitet
FR2670669B1 (fr)	1993-03-12	Instrument de correction chirurgicale de l'astigmatisme.
LU92263I2 (fr)	2013-10-07	Imépitoïne et ses dérivés pharmaceutiquement acceptables (PEXION)
PT1119359E (pt)	2004-08-31	Formulacao de 2-metil-tieno-benzodiazepina
GB2380939B (en)	2003-09-10	Treatment or prevention of auto-immune diseases
FI970449A0 (fi)	1997-02-03	N-substituoituja atsabisykloheptaanijohdannaisia, jotka ovat käyttökelpoisia neuroleptisinä aineina
TW330933B (en)	1998-05-01	Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
NO990450D0 (no)	1999-01-29	Behandling av sinnslidelser
GR3034688T3 (en)	2001-01-31	Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
NZ336249A (en)	2000-11-24	parenteral composition of a dihydropolyprenol and a pharmaceutically acceptable oil
TR199701011A2 (xx)	1998-04-21	1-karba-(detia)-sefalosforin t�revleri.
BR9712628A (pt)	1999-10-26	Derivados de 8(9)-deidroestradiol
FI920839A0 (fi)	1992-02-26	Anordning foer reglering av floete och rev i metspoe.
GR930100335A (el)	1994-03-31	Ενώσεις και μέ?οδοι αναστολής του ΗΙV και των σχετικών ιών.